Identification of a new androgen receptor (AR) co‐regulator BUD31 and related peptides to suppress wild‐type and mutated AR‐mediated prostate cancer growth via peptide screening and X‐ray structure analysisCheng-Lung Hsu, Chawnshang Chang, Huei‐Ju Ting et al.|Molecular Oncology|2014Cited by 58
Integrated genomic analyses in PDX model reveal a cyclin-dependent kinase inhibitor Palbociclib as a novel candidate drug for nasopharyngeal carcinomaCheng-Lung Hsu, Hsin-Pai Li, Kar‐Wai Lui et al.|Journal of Experimental & Clinical Cancer Research|2018Cited by 36
Characterization of a novel androgen receptor (AR) coregulator RIPK1 and related chemicals that suppress AR-mediated prostate cancer growth via peptide and chemical screeningCheng-Lung Hsu, Wen-guey Wu, Ting-Wei Lin et al.|Oncotarget|2017Cited by 6